Fuan Pharmaceutical Group Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fuan Pharmaceutical Group Co Ltd with three other
companies in this sector in China:
Xiamen Kingdomway Group Co
sales of 2.08 billion Chinese Renmimbi [US$304.42 million]
of which 99%
PKU HealthCare Corp Ltd
(2.15 billion Chinese Renmimbi [US$313.37 million]
of which 80%
was Merchandise&Material Selling), and
Tianjin Tianyao Pharmaceutical, Ltd.
(1.97 billion Chinese Renmimbi [US$287.93 million]
During the year ended December of 2017, sales at
Fuan Pharmaceutical Group Co Ltd were 2.09 billion Chinese Renmimbi (US$305.32 million).
increase of 61.2%
versus 2016, when the company's sales were 1.30 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Fuan Pharmaceutical Group Co Ltd.